MiR-141 dramatically boosted the level of phosphorylated AKT in NSCLC cells while deregulating the inhibitory effects of PHLPP1 and PHLPP2, which block the PI3K/AKT signaling pathway and slow NSCLC cell proliferation (23). This evidence concerns the gene PIK3CB and non-small cell lung carcinoma.